CLEVELAND, Feb. 22, 2017 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) announced today that Chris Raanes, Chief Executive Officer, and Ajay Bansal, Chief Financial Officer, are scheduled to participate in two upcoming investor conferences.
The first conference is the 2017 BTIG Medical Technology, Life Science and Diagnostic Tools Conference in Snowbird, Utah from February 28, 2017 through March 2, 2017. This conference will allow institutional investors to meet with the Company but does not include a formal presentation. BTIG's annual conference brings together over 70 leading healthcare companies with institutional investor clients.
|
Event: |
2017 BTIG Medical Technology, Life Science and Diagnostic Tools Conference |
|
Date: |
Wednesday, March 1 - Thursday, March 2, 2017 |
|
Participants: |
Ajay Bansal, Chief Financial Officer |
The second conference is the Cowen and Company 37th Annual Health Care Conference in Boston, MA. This conference includes a formal presentation and will allow institutional investors to meet with the Company.
|
Event: |
Cowen and Company 37th Annual Health Care Conference |
|
Date: |
Monday, March 6, 2017 |
|
Time: |
1:20pm ET |
|
Participants: |
Chris Raanes, Chief Executive Officer, and Ajay Bansal, Chief Financial Officer |
An audio webcast of the Company's presentation at the Cowen Health Care conference will be available by visiting the investor relations section of ViewRay's website at www.viewray.com. A replay of the webcast will be available for 30 days after the date of the presentation.
About ViewRay
ViewRay®, Inc. (Nasdaq: VRAY) designs, manufactures and markets the MRIdian® radiation therapy system. MRIdian integrates MRI technology, radiation delivery and proprietary software to locate, target and track the position and shape of soft-tissue tumors during radiation. ViewRay believes this combination of enhanced visualization and accuracy will significantly improve outcomes for patients.
ViewRay and MRIdian are registered trademarks of ViewRay, Inc.
SOURCE ViewRay, Inc.